Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated (18)F–Fluorodeoxyglucose ((18)F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study

BACKGROUND: Tyrosine kinase inhibitors are the first line standard of care for treatment of metastatic renal cell carcinoma (RCC). Accurate response assessment in the setting of antiangiogenic therapies remains suboptimal as standard size-related response criteria do not necessarily accurately refle...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Cancer
Main Authors: Kelly-Morland, Christian, Rudman, Sarah, Nathan, Paul, Mallett, Susan, Montana, Giovanni, Cook, Gary, Goh, Vicky
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Study Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455133/
https://ncbi.nlm.nih.gov/pubmed/28578690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3371-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker